Share on StockTwits

Analysts at Deutsche Bank upped their target price on shares of LifePoint Hospitals (NASDAQ:LPNT) from $63.00 to $75.00 in a research report issued to clients and investors on Monday. The firm currently has a “buy” rating on the stock. Deutsche Bank’s price objective points to a potential upside of 15.88% from the stock’s previous close.

In other LifePoint Hospitals news, Director Richard H. Evans unloaded 1,000 shares of the company’s stock on the open market in a transaction dated Thursday, June 12th. The stock was sold at an average price of $64.05, for a total transaction of $64,050.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of LifePoint Hospitals (NASDAQ:LPNT) traded up 0.77% on Monday, hitting $65.22. 345,851 shares of the company’s stock traded hands. LifePoint Hospitals has a one year low of $43.97 and a one year high of $65.07. The stock’s 50-day moving average is $60.88 and its 200-day moving average is $55.0. The company has a market cap of $2.901 billion and a price-to-earnings ratio of 23.29.

LifePoint Hospitals (NASDAQ:LPNT) last announced its earnings results on Friday, April 25th. The company reported $0.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.65 by $0.13. The company had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $1,000.00 million. During the same quarter in the previous year, the company posted $0.79 earnings per share. The company’s revenue for the quarter was up 8.2% on a year-over-year basis. On average, analysts predict that LifePoint Hospitals will post $2.70 earnings per share for the current fiscal year.

A number of other analysts have also recently weighed in on LPNT. Analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of LifePoint Hospitals in a research note on Tuesday, June 3rd. They now have a $65.00 price target on the stock, up previously from $62.00. Separately, analysts at Mizuho upgraded shares of LifePoint Hospitals from a “neutral” rating to a “buy” rating in a research note on Friday, May 30th. They now have a $72.00 price target on the stock, up previously from $58.00. Finally, analysts at FBR Capital Markets reiterated a “market perform” rating on shares of LifePoint Hospitals in a research note on Monday, April 28th. They now have a $58.00 price target on the stock. Seven equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $62.65.

LifePoint Hospitals, Inc (NASDAQ:LPNT), through its subsidiaries, operates general acute care hospitals in non-urban communities in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.